MARKET

ALKS

ALKS

Alkermes
NASDAQ

Real-time Quotes | Nasdaq Last Sale

14.42
+0.02
+0.14%
After Hours: 14.42 0 0.00% 17:30 03/31 EDT
OPEN
14.39
PREV CLOSE
14.40
HIGH
14.78
LOW
14.10
VOLUME
2.52M
TURNOVER
--
52 WEEK HIGH
37.75
52 WEEK LOW
11.98
MARKET CAP
2.28B
P/E (TTM)
-11.4955
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ALKS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 14 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ALKS stock price target is 21.50 with a high estimate of 28.00 and a low estimate of 17.00.

EPS

ALKS News

More
  • Here is What Hedge Funds Think About Alkermes Plc (ALKS)
  • Insider Monkey · 1d ago
  • The Top 10 Biotechnology Companies
  • Investopedia · 5d ago
  • The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
  • Benzinga · 03/18 11:36
  • Alkermes (ALKS) Down 8.6% Since Last Earnings Report: Can It Rebound?
  • Zacks · 03/14 16:30

Industry

Biotechnology & Medical Research
-0.25%
Pharmaceuticals & Medical Research
-0.17%

Hot Stocks

Symbol
Price
%Change

About ALKS

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS). The Company's products include ARISTADA, VIVITROL, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, TREVICTA, RISPERDAL CONSTA, AMPYRA, FAMPYRA, BYDUREON, Aripiprazole lauroxil, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, ALKS 4230 and ALKS 7119. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.
More

Webull offers kinds of Alkermes Plc stock information, including NASDAQ:ALKS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALKS stock news, and many more online research tools to help you make informed decisions.